Join the AST email update service.

Order Online

Contact AST

Sign-up For the Max-OT 12-Week On-line Training Course

 

19-nor_3-andro_banner-1.jpg (15282 bytes)

Breaking Research For 7-7-99

 


Dymetadrine Xtreme's Active Substrates
Prevent Decline in HDL While
Enhancing Fat Loss


 

 

An 8 week study looking into the effects of ephedrine and caffeine on plasma HDL-cholesterol revealed a positive contribution to a "good" cholesterol profile.

Thirty-two women were randomly assigned to either 20 mg ephedrine plus 200 mg caffeine or a placebo three times per day while following an energy restricted diet. During the 8 week study total cholesterol concentration declined from baseline in both groups. This was expected. What was surprising was while the HDL-cholesterol concentration decreased at week 4 and week 8 in the placebo group it remained unchanged in the ephedrine-caffeine group. No effect of dieting was seen on plasma triglyceride concentration in the placebo group but a decrease was observed in the ephedrine-caffeine group at week 8. 

This study suggests that ephedrine-caffeine combinations abolish the decline in HDL-cholesterol during active weight loss due to the beta-agonistic properties of ephedrine.

 

 

Back To Breaking Research Main Page

 

| Home | Mission | Products | New Products | Q&A | Breaking Research | Orders | Weekly Tips |
|
Monthly Special | Terminology | Free Issue High-Performance Muscle | Latest News | Links |

| Daily Q&A | Employment Opportunities | World Wide Distribution | The Ultimate Andro Q&A |
| AST Sports Science European Sales | AST-Medline Search | Mass Builder Supplement Schedule |

© 2000 AST Sports Science, Inc.  All rights reserved.

Home

Privacy Policy

Terms of Use

Contact Information